Publications by authors named "Masayuki Shimojima"

In 2014, an outbreak of zoonotic Nipah virus (NiV) occurred on Mindanao Island, the Philippines. We investigated the prevalence of NiV in Philippine bats. Because neutralizing antibodies were detected in insectivorous bats on Siargao Island, public health officials should consider that the distribution range of NiV is not limited to Mindanao Island.

View Article and Find Full Text PDF

Despite the recent mpox outbreak raising global concerns, no fully validated antiviral treatment exists, highlighting the urgent need for effective therapeutics. Here, by taking advantage of the preparation technology for single-domain (VHH) antibodies, we generated VHHs targeting the six major mpox virus (MPXV) surface antigens. Although neutralization activity of these monoclonal VHH monomers was negligible, bivalent VHHs against MPXV-M1R (bi-M1A8 and bi-M1C2) improved the antigen binding affinity by up to over 400-fold compared with the monomer VHH and thus produced neutralizing activity against MPXV.

View Article and Find Full Text PDF

Endogenous retroviruses (ERVs) are remnants of ancestral viral infections in germ cells that constitute a substantial proportion of the mammalian genome and are assumed to provide molecular fossil records of ancient infections. Analysis of these sequences may reveal the mechanisms of virus-host co-evolution, viral endogenization, and extinction. Chimpanzee endogenous retrovirus 1 (CERV1), a gamma retrovirus, is estimated to have circulated within primates for ~10 million years, although it is now apparently extinct.

View Article and Find Full Text PDF

Unlabelled: Betacoronaviruses, which have caused three human outbreaks within the last two decades, are thought to originate from bats, raising the concern that bat coronaviruses could cause a novel human outbreak in the future. To determine whether the bat merbecovirus EjCoV-3 strain, previously detected in in Japan, has the potential to infect humans, we analyzed its cellular entry mechanism. Cellular entry of EjCoV-3 via the spike protein requires protease treatment and is mediated by an unknown receptor, other than DPP4 or ACE2.

View Article and Find Full Text PDF

To address the global emergence of mpox after the 2022 epidemic, a rapid and accurate diagnostic tool is needed at the point of care to identify individuals infected with mpox virus (MPXV) to prevent and control the spread of the virus. We designed an antigen-detecting rapid diagnostic test that exclusively detects MPXV without cross-reacting with the vaccinia virus by developing monoclonal antibodies against the MPXV nuclear capsid protein A5L (MPXV-A5L). The test results indicated that the detection limits were established at 0.

View Article and Find Full Text PDF

Severe dengue is characterized by vascular leakage triggered by a hyperinflammatory response, though the underlying mechanisms remain unclear. Our previous mouse model study highlighted the importance of small intestine in severe disease and identified key cytokines (IL-17A, TNF-α, and IL-6) involved. Here, we used a Fixed RNA Profiling assay to characterize key cytokine- and effector-producing cells, along with their receptor expression.

View Article and Find Full Text PDF
Article Synopsis
  • Severe fever with thrombocytopenia syndrome (SFTS) is a tick-borne disease caused by Dabie bandavirus, first reported in Thailand in 2019.
  • The study highlights a One Health investigation, revealing that domestic dogs and cats may act as potential reservoirs for the virus, while no SFTSV was found in local ticks or wild animals.
  • The authors emphasize the need for integrated surveillance using genomic and serologic methods to better understand SFTS and prevent its spread among humans and animals in East Asia.
View Article and Find Full Text PDF

Severe fever with thrombocytopenia syndrome (SFTS) virus, a tick-borne bunyavirus, causes a severe/fatal disease termed SFTS; however, the viral virulence is not fully understood. The viral non-structural protein, NSs, is the sole known virulence factor. NSs disturbs host innate immune responses and an NSs-mutant SFTS virus causes no disease in an SFTS animal model.

View Article and Find Full Text PDF

Introduction: Severe dengue is thought to be caused by an excessive host immune response.

Methods: To study the pathogenesis of severe dengue, we developed a novel model using LysM Cre mice carrying depleted expression only in subsets of murine myeloid cells.

Results: Although dengue virus (DENV) clinical isolates were not virulent in LysM Cre mice, mouse-adapted DV1-5P7Sp and DV3P12/08P4Bm, which were obtained by passaging the spleen or bone marrow of mice, demonstrated 100% lethality with severe vascular leakage in the liver and small intestine.

View Article and Find Full Text PDF
Article Synopsis
  • The study evaluated the LC16m8 vaccine's safety and effectiveness against the monkeypox virus (MPXV) in 50 healthy adults over 168 days.
  • On day 28, the vaccine showed strong immunogenicity, with 72% to 88% seroconversion rates, although these rates declined by day 168.
  • Adverse events were common but mostly mild, and no serious safety issues or cases of monkeypox were reported during the study period.
View Article and Find Full Text PDF

Introduction: Severe fever with thrombocytopenia syndrome (SFTS) is a fatal viral disease characterized by high fever, thrombocytopenia, leukopenia, and multi-organ haemorrhage. Disruption of the humoral immune response and decreased lymphocyte numbers are thought to contribute to the disease severity. These findings have been obtained through the analysis of peripheral blood leukocytes in human patients, whereas analysis of lymph nodes has been limited.

View Article and Find Full Text PDF

Biosafety Level 4 facilities have been established in our country to promote research and development and national capacity of diagnostic test systems for infectious diseases, including highly pathogenic viruses. In particular, the operation of a suit-type laboratory requiring positive pressure protective suits is a first for our country, and it is necessary to establish unique safety management technology. With the support of the Research Program on Emerging and Re-emerging Infectious Diseases of the Japan Agency for Medical Research and Development (AMED), we conducted research entitled "Study of Practical Biorisk Management in the Microbiological Containment Laboratories" from 2021 to 2023, with the aim of improving biosafety management technology in Japan.

View Article and Find Full Text PDF
Article Synopsis
  • Nipah virus (NiV) is a dangerous virus causing severe illness in humans with a mortality rate over 40%, primarily transmitted by fruit bats found in Southeast Asia.
  • Researchers developed recombinant vaccinia viruses that express NiV proteins to test their effectiveness at producing immune responses, finding that they successfully induced higher levels of neutralizing antibodies in hamsters than previous vaccine candidates.
  • The study suggests that the LC16m8-based vaccines have promising potential for future clinical use against NiV disease, marking a significant step towards effective prevention methods.
View Article and Find Full Text PDF

Heartland virus (HRTV) causes generalized symptoms, severe shock, and multiple organ failure. We previously reported that interferon-α/β receptor knockout (IFNAR) mice infected intraperitoneally with 1 × 10 tissue culture-infective dose (TCID) of HRTV died, while those subcutaneously infected with the same dose of HRTV did not. The pathophysiology of IFNAR mice infected with HRTV and the mechanism underlying the difference in disease severity, which depends on HRTV infection route, were analyzed in this study.

View Article and Find Full Text PDF

Introduction: Severe fever with thrombocytopenia syndrome (SFTS) is a tick-borne infectious disease caused by the SFTS virus (SFTSV). The Miyazaki Prefecture has the highest number of SFTS cases in Japan and requires countermeasures for prevention. In this study, we aimed to conduct an epidemiological survey in Miyazaki Prefecture to determine the exposure conditions of SFTSV by measuring the seroprevalence among residents of Miyazaki and to evaluate the factors that influence the endemicity of SFTS.

View Article and Find Full Text PDF
Article Synopsis
  • - Tecovirimat's role in treating mpox is still not well-understood, prompting a study in Japan to assess its effectiveness and safety across various patient demographics from June 2022 to April 2023.
  • - In the study, 19 male patients (average age 38.5 years), primarily with severe disease and many HIV positive, were treated with tecovirimat; results showed that 60% had negative virus tests in their skin lesions within two weeks, with no severe side effects reported.
  • - The findings suggest that starting tecovirimat treatment early can likely shorten the time the virus is detectable, especially in HIV-infected patients, who tend to shed the virus longer, raising the risk of transmission
View Article and Find Full Text PDF

Dengue is a major health problem in tropical and subtropical regions. Some patients develop a severe form of dengue, called dengue hemorrhagic fever, which can be fatal. Severe dengue is associated with a transient increase in vascular permeability.

View Article and Find Full Text PDF
Article Synopsis
  • Manipulating viral genomes is crucial for reverse genetics and vaccine development, utilizing bacterial artificial chromosomes (BACs) to insert and modify viral DNA.
  • A markerless DNA manipulation method for BACs, using the GS1783 strain and pEPKan-S plasmid, allows for efficient genetic recombination, though it currently has limitations in selective markers and can yield false negatives.
  • A new recombineering method with fluorescent protein markers enhances this process by providing a clear indication of successful recombination, which was tested by integrating Lassa virus genes into BACs linked with the vaccinia virus, aiding in selection through visible fluorescent signals.
View Article and Find Full Text PDF
Article Synopsis
  • Monkeypox has seen outbreaks outside its original West African regions since May 2022, prompting a study on the effectiveness of tecovirimat, a drug estimated to be effective against both smallpox and monkeypox.
  • This nationwide study involves patients taking tecovirimat for 14 days and will compare results from those receiving the treatment versus a control group that only gets supportive care, measuring outcomes like viral load and adverse effects.
  • Participants will be financially supported through research funding, and all ethical guidelines, including informed consent, will be followed; findings will be shared in academic publications and conferences.
View Article and Find Full Text PDF

Mpox virus (formerly monkeypox virus [MPXV]) is a neglected zoonotic pathogen that caused a worldwide outbreak in May 2022. Given the lack of an established therapy, the development of an anti-MPXV strategy is of vital importance. To identify drug targets for the development of anti-MPXV agents, we screened a chemical library using an MPXV infection cell assay and found that gemcitabine, trifluridine, and mycophenolic acid (MPA) inhibited MPXV propagation.

View Article and Find Full Text PDF

Monkeypox (mpox) is an acute exanthematous disease caused by the monkeypox virus (MPXV). Since May 2022, patients with mpox have been reported worldwide, mainly in Europe and the Americas. In Japan, LC16"KMB," which is a smallpox vaccine derived from a dried cell culture, against mpox, has been approved.

View Article and Find Full Text PDF

RNA viruses are the etiological agents of many infectious diseases. Since RNA viruses are error-prone during genome replication, rapid, accurate and economical whole RNA viral genome sequence determination is highly demanded. Next-generation sequencing (NGS) techniques perform whole viral genome sequencing due to their high-throughput sequencing capacity.

View Article and Find Full Text PDF
Article Synopsis
  • Mpox virus (MPXV) outbreak in 2022 prompted research into potential drug candidates for treatment, as existing anti-smallpox drugs' effects on mpox were unclear.
  • A study screened 132 drugs, identifying atovaquone, mefloquine, and molnupiravir as effective against MPXV, with atovaquone showing the most promise by enhancing the effectiveness of the drug tecovirimat.
  • Mathematical models predict that atovaquone could help clear the virus from patients more quickly, suggesting it's a strong candidate for mpox treatment.
View Article and Find Full Text PDF

Severe fever with thrombocytopenia syndrome is a hemorrhagic fever caused by a tick-borne infection. The causative agent, Dabie bandavirus, is also called the severe fever with thrombocytopenia syndrome virus (SFTSV). Ogawa et al.

View Article and Find Full Text PDF

Orthomyxo- and bunyaviruses steal the 5' cap portion of host RNAs to prime their own transcription in a process called "cap snatching." We report that RNA modification of the cap portion by host 2'-O-ribose methyltransferase 1 (MTr1) is essential for the initiation of influenza A and B virus replication, but not for other cap-snatching viruses. We identified with in silico compound screening and functional analysis a derivative of a natural product from , called trifluoromethyl-tubercidin (TFMT), that inhibits MTr1 through interaction at its -adenosyl-l-methionine binding pocket to restrict influenza virus replication.

View Article and Find Full Text PDF